Hannah Shaw

Researcher

UAMS

Also affiliated: Translational Research Institute (2017); The University of Queensland (2017); Leeds Teaching Hospitals NHS Trust (2021); Mater Research (2017)

Unknown Researcher

2 h-index 8 pubs 56 cited

Research Areas

Biomedical Subjects

OverviewAI-generated summary

Hannah Shaw's research focuses on understanding the pharmacological effects and potential toxicity of various substances, particularly in combination therapies and overdose scenarios. Her work has investigated the respiratory depressant effects of fentanyl when combined with synthetic cannabinoid receptor agonists, exploring mechanisms that may contribute to overdose resistance to naloxone. Shaw also contributes to the study of cardiovascular function, with a publication examining the diagnostic utility of right sternal edge continuous-wave Doppler in patients with stenotic bicuspid aortic valves. Her scholarship metrics include an h-index of 2, with 8 total publications and 55 citations. Shaw collaborates with colleagues at the University of Arkansas for Medical Sciences, including Brenda M. Gannon, William E. Fantegrossi, and J S James, with whom she has co-authored publications.

Metrics

h-index: 2
Publications: 8
Citations: 56

Selected Publications

Respiratory Depressant Effects of Fentanyl in Combination With Synthetic Cannabinoid Receptor Agonists: A Potential Mechanism for “Narcan-Resistant” Overdose (2024)

Drug and Alcohol Dependence DOI OpenAlex

View all publications on OpenAlex →